Prophylactic Irradiation of the Contralateral Breast for BRCA Carriers With Early Breast Cancer

Scientists reported the long-term results of a prospective nonrandomized Phase II trial of prophylactic radiation therapy to the contralateral breast in BRCA pathogenic variant carriers with early breast cancer who forego risk-reducing mastectomy.